TABLE 3.

Source characteristics of the 169 E. coli ST131 study isolates

Origin	Location	Type of studya	Sampling period	No. of isolates (n = 169)	Source or reference
Czech Republic				159
Humansc
Hospital 1 (H1)	South Moravian Region: Brno	ESBL E. coli from patients with UTIs	2008–2011	93	33
Hospital 2 (H2)	South Moravian Region: Brno	ESBL E. coli from patient with febrile neutropenia	2009	1	31
Hospital 3 (H3)	Prague Region: Prague	FQ-R E. coli from urine samples	2011–2012	35	NPb
Community (CO)	Moravian-Silesian Region: Karvina	E. coli from cultivation on MCA	2012	1	NP
WWTPd
Treated municipal wastewaters	South Moravian Region: Brno	E. coli from selective cultivation on MCACTX	2008–2009	18	30
Wildlife
Rooks	South Moravian Region: Prerov	E. coli from selective cultivation on MCACTX	2010	8	25
Rooks	South Moravian Region: Zidlochovice	E. coli from selective cultivation on MCACTX	2012	1	NP
Great cormorants	South Moravian Region: Straznicee	E. coli from selective cultivation on MCACTX	2008	2	32
International isolates				10
WWTP
Treated municipal wastewaters	Slovakia	E. coli from cultivation on MCA	2011–2013	1	NP
Wildlife
Rooks	Poland	E. coli from selective cultivation on MCACTX	2011	1	25
Rooks	Serbia	E. coli from selective cultivation on MCACTX	2011	3	25
American crows	United States	E. coli from selective cultivation on MCACTX	2012	2	26
Companion animals
Dogs	Kenya	E. coli from selective cultivation on MCACTX	2009	3	34

^aMCA, MacConkey agar; MCA_CTX, MacConkey agar supplemented with cefotaxime (2 mg/liter); ESBL, extended-spectrum beta-lactamases; UTI, urinary tract infection; FQ-R, fluoroquinolone resistant.

^bNP, not published.

^cH, human clinical isolates: H1, St. Anne's Faculty Hospital, Brno, CZ; H2, Children's Medical Center, Brno, CZ; H3, University Hospital Motol, Prague, CZ; CO: human community isolate, Karvina, CZ.

^dWWTP, wastewater treatment plant.

^eNature Reserve Oskovec.